氯硝柳胺
重新调整用途
药品
硝唑烷
Wnt信号通路
药物重新定位
驱虫药
药物发现
药理学
被忽视的热带疾病
PI3K/AKT/mTOR通路
药物开发
生物
疾病
医学
生物信息学
信号转导
免疫学
内科学
生态学
生物化学
作者
Hachemi Kadri,Olivia A. Lambourne,Youcef Mehellou
出处
期刊:ChemMedChem
[Wiley]
日期:2018-03-31
卷期号:13 (11): 1088-1091
被引量:90
标识
DOI:10.1002/cmdc.201800100
摘要
Niclosamide is an anthelmintic drug that has been used for over 50 years mainly to treat tapeworm infections. However, with the increase in drug repurposing initiatives, niclosamide has emerged as a true hit in many screens against various diseases. Indeed, from being an anthelmintic drug, it has now shown potential in treating Parkinson's disease, diabetes, viral and microbial infections, as well as various cancers. Such diverse pharmacological activities are a result of niclosamide's ability to uncouple mitochondrial phosphorylation and modulate a selection of signaling pathways, such as Wnt/β-catenin, mTOR and JAK/STAT3, which are implicated in many diseases. In this highlight, we discuss the plethora of diseases that niclosamide has shown promise in treating.
科研通智能强力驱动
Strongly Powered by AbleSci AI